| For: | Li JJ, Mao JX, Zhong HX, Zhao YY, Teng F, Lu XY, Zhu LY, Gao Y, Fu H, Guo WY. Multifaceted roles of lymphatic and blood endothelial cells in the tumor microenvironment of hepatocellular carcinoma: A comprehensive review. World J Hepatol 2024; 16(4): 537-549 [PMID: 38689749 DOI: 10.4254/wjh.v16.i4.537] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i4/537.htm |
| Number | Citing Articles |
| 1 |
Huiquan Lou, Yichao Xia, Shengjie Shao, Xiang Liu, Zengzheng Li, Hongbin Yu, Yongsheng Li. CXCR4/CXCL12 axis promotes lymphatic metastasis in tongue squamous cell carcinoma via PI3K/AKT signaling pathway. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06707-9
|
| 2 |
Haohuan Li, Chao Cui, Chenglu Sun, Ziyu Chen, Dengfeng Gao, Peng Yuan, Shibo Tian, Qin Zhong, Funeng Xu, Xiaoxia Liang, Long Jin, Keren Long, Lu Lu, Juan Deng, Jiaxue Cao, Xiaolan Fan, Fanli Kong, Chengdong Wang, Desheng Li, Zhiyong Qian, Mingzhou Li. Targeting the Golgi apparatus enhances PD-L1 blockade and synergizes with oxaliplatin to improve immunotherapy efficacy. Journal of Biological Chemistry 2026; : 111343 doi: 10.1016/j.jbc.2026.111343
|
| 3 |
Hanie Mahaki, Sima Nobari, Hamid Tanzadehpanah, Ali Babaeizad, Gholamhosein Kazemzadeh, Mohsen Mehrabzadeh, Arezoo Valipour, Nader Yazdinezhad, Hamed Manoochehri, Piao Yang, Mohsen Sheykhhasan. Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: Therapeutic strategies and insights. Biomedicine & Pharmacotherapy 2025; 186: 118023 doi: 10.1016/j.biopha.2025.118023
|
| 4 |
Jia-Xi Mao, Jing-Jing Li, Xin-Yi Lu, Han-Xiang Zhong, Yuan-Yu Zhao, Li-Ye Zhu, Hong Fu, Guo-Shan Ding, Fei Teng, Ming Chen, Wen-Yuan Guo. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance. International Immunopharmacology 2024; 136: 112340 doi: 10.1016/j.intimp.2024.112340
|
| 5 |
Swayam Aryam Behera, Binita Nanda, P. Ganga Raju Achary. Recent advancements and challenges in 3D bioprinting for cancer applications. Bioprinting 2024; 43: e00357 doi: 10.1016/j.bprint.2024.e00357
|
